Growth Metrics

Elutia (ELUT) Liabilities and Shareholders Equity (2019 - 2026)

Elutia recorded quarterly Liabilities and Shareholders Equity of $55.2 million in Q1 2026, down 11.45% quarter-over-quarter from $62.4 million in Q4 2025, and up 40.49% year-over-year from $39.3 million in Q1 2025.

Elutia's Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $55.2 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 40.49% year-over-year to $55.2 million; the TTM figure through Mar 2026 stood at $180.8 million (up 9.1% YoY), while the FY2025 annual figure was $62.4 million, up 72.59% from the prior year.
  • Liabilities and Shareholders Equity came in at $55.2 million for Q1 2026 at Elutia, down from $62.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $68.8 million in Q4 2022 to a low of $29.4 million in Q3 2025.
  • A 5-year average of $49.1 million and a median of $52.3 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity sank 41.68% in 2024 and soared 72.59% in 2025, its largest moves.
  • Elutia's Liabilities and Shareholders Equity stood at $68.8 million in 2022, then plunged by 36.92% to $43.4 million in 2023, then dropped by 16.81% to $36.1 million in 2024, then jumped by 72.59% to $62.4 million in 2025, then dropped by 11.45% to $55.2 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $55.2 million, $62.4 million, and $29.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Elutia 45.79 Mn 17.31 Mn 1.80 Mn 55.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 55.21 Mn
Dec 31, 2025 62.35 Mn
Sep 30, 2025 29.41 Mn
Jun 30, 2025 33.85 Mn
Mar 31, 2025 39.30 Mn
Dec 31, 2024 36.13 Mn
Sep 30, 2024 48.41 Mn
Jun 30, 2024 41.90 Mn
Mar 31, 2024 35.36 Mn
Dec 31, 2023 43.43 Mn
Sep 30, 2023 54.58 Mn
Jun 30, 2023 52.33 Mn
Mar 31, 2023 60.63 Mn
Dec 31, 2022 68.84 Mn
Sep 30, 2022 61.02 Mn
Jun 30, 2022 52.85 Mn
Mar 31, 2022 59.93 Mn
Dec 31, 2021 67.17 Mn
Sep 30, 2021 59.90 Mn
Jun 30, 2021 69.70 Mn
Mar 31, 2021 74.21 Mn
Dec 31, 2020 82.81 Mn
Sep 30, 2020 46.14 Mn
Dec 31, 2019 44.77 Mn